J

JEENA SIKHO LIFECARE LTD

JSLLNSE
Market snapshot · 2026-08-10 21:47 UTC

₹539.95

₹-58.15 (-9.72%)

MARKET CAP

₹6.71K Cr

STOCK P/E

30.3x

52W HIGH

₹849.50

52W LOW

₹492.00

BOOK VALUE

₹37.57

EPS

₹17.82

ROE

—

SECTOR

Health Care

DEBT/EQUITY

27.26

VOLUME

37.19L

P/B RATIO

14.37x

PEG RATIO

1.18

Sector

Health Care

Themes

Pharmaceuticals
D
Dividend
₹815.10₹749.74₹684.38₹619.01₹553.65VolumeDAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 19.4% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.78). Confidence: 50%.

Live forward EPS implies next-12-month EPS of ₹35.80. Applying the stock's normalized valuation corridor produces a fair range of ₹1,259.44 to ₹2,783.09, with base value near ₹1,490.71 (+176.1% vs current price).

Forward Valuation Outlook

Live forward estimate anchored to the company's historical valuation corridor.

Below normalized range

Forward EPS

₹35.80

Forward P/E

15.1x

Base Fair Value

₹1,490.71

Fair Range

₹1,259.44 - ₹2,783.09

Upside To Base

+176.1%

Estimate Source

Live forward EPS

Growth Estimate

+28.4%

P/E
Strongly Undervalued

5Y Average

44.15

Current

33.56

Overvalued

77.74

Undervalued

35.18

EV/EBITDA
Strongly Undervalued

5Y Average

26.36

Current

18.09

Overvalued

35.01

Undervalued

11.27

P/S
Strongly Undervalued

5Y Average

11.49

Current

7.88

Overvalued

15.25

Undervalued

4.91

Peers & Comparison

Sector: Health Care · Theme: Pharmaceuticals

Pharmaceuticals Peers7 peers
Avg P/E: 66.4x
CompanyRev. GrowthMarginP/Evs Avg52W Perf.
AKUMS DRUGS AND PHARMA L
AKUMSPharmaceuticals
+9.6%5.9%
43.8x
Undervalued
-34% vs avg
+45.4%
BLUE JET HEALTHCARE LTD
BLUEJETPharmaceuticals
-17.4%26.5%
43.7x
Undervalued
-34% vs avg
-25.8%
CAPLIN POINT LAB LTD.
CAPLIPOINTPharmaceuticals
+19.0%29.3%
31.2x
Undervalued
-53% vs avg
+22.1%
ALIVUS LIFE SCIENCES LTD
ALIVUSPharmaceuticals
+6.4%23.3%
28.0x
Undervalued
-58% vs avg
+43.4%
CONCORD BIOTECH LIMITED
CONCORDBIOPharmaceuticals
+26.2%24.8%
48.8x
Undervalued
-27% vs avg
-14.9%
ASTRAZENECA PHARMA IND LT
ASTRAZENPharmaceuticals
+20.4%8.2%
107.4x
Premium
+62% vs avg
-6.9%
COHANCE LIFESCIENCES LTD
COHANCEPharmaceuticals
-23.1%5.0%
162.0x
Premium
+144% vs avg
-52.7%
WHY THESE PEERS

JEENA SIKHO LIFECARE LTD trades at a discount (30.3x vs peer avg 66.4x), suggesting potential undervaluation relative to the Pharmaceuticals cohort. Peers include AKUMS DRUGS AND PHARMA L, BLUE JET HEALTHCARE LTD, CAPLIN POINT LAB LTD. — selected based on business model, industry classification, market cap similarity, and business theme alignment.

Financials

Financial chart data is not available for this company right now.

Results

Income statement data not available.

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +63.53%63.61%63.62%63.62%63.62%
FIIs +5.91%6.59%6.31%6.17%4.78%
DIIs +0.18%0.15%0.11%0.46%0.36%
Public +30.38%29.65%29.97%29.77%31.24%
Jun 2026
Promoters +
FIIs +
DIIs +
Public +

Events Timeline

Announcement under Regulation 30 (LODR)-Investor Presentation

Aug 09, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 09, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Management

Aug 07, 2026PDFCompany Reports Open

Outcome Of The Meeting Of The Board Of Jeena Sikho Lifecare Limited Held On August 07, 2026

Aug 07, 2026PDFCompany Reports Open

Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Jeena Sikho Lifecare Limited Held On August 07, 2026

Aug 07, 2026PDFCompany Reports Open